Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack. [PDF]
Lin J +15 more
europepmc +1 more source
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. [PDF]
Lee KJ +18 more
europepmc +1 more source
Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders. [PDF]
Chenchula S +8 more
europepmc +1 more source
Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]
Zhao J +11 more
europepmc +1 more source
Toward a More accurate, Evidence-Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems. [PDF]
Backman JT.
europepmc +1 more source
The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. [PDF]
Schmith VD +4 more
europepmc +1 more source
Comprehensive Molecular Evaluation of Transcription Factor 7-like 2, Long Noncoding RNA (ANRIL), and CYP2C19*17 Gene Variants and Their Association with Predisposition and Progression in Stroke Patients. [PDF]
Hamadi A +10 more
europepmc +1 more source
Multi-omics analysis of key lipid metabolism-related genes involved in the anti-hepatocellular carcinoma effect of dihydroartemisinin. [PDF]
Guo J +6 more
europepmc +1 more source

